Logo 1200x628.jpg
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
04. November 2024 07:00 ET | CytoSorbents
CytoSorbents submits DrugSorb-ATR Medical Device License Application to Health Canada following MDSAP Certification. Expects regulatory decision in 2025
UMeWorld to Debut the World's First & Only Weight Loss Cooking Oil in the US
09. April 2024 08:00 ET | UMeWorld Limited
MIAMI, April 09, 2024 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) is excited to announce that the company has secured an exclusive license to use proprietary enzymatic technologies to...
PMcardio by Powerful Medical
Powerful Medical Secures €7.5M in Funding from European Innovation Council to Revolutionize Heart Attack Diagnostics with AI
01. März 2024 05:49 ET | Powerful Medical
Powerful Medical Secures €7.5M in Funding from European Innovation Council to Revolutionize Heart Attack Diagnostics with AI
New Study Links Heart Attack Deaths to Particulate Matter Exposure, Camfil Air Quality Professionals Explain
06. Dezember 2023 22:04 ET | Camfil USA Air Filters
Riverdale, Dec. 06, 2023 (GLOBE NEWSWIRE) -- A study published earlier this year found that the risk of death from a heart attack could potentially double when both temperatures and ambient levels...
Global Thrombosis and Hemostasis Biomarkers Market
Thrombosis And Hemostasis Biomarkers Research Report 2023: Point-of-Care Analyzers Gain Traction - Global Forecast to 2030
22. November 2023 07:18 ET | Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Thrombosis And Hemostasis Biomarkers Market Size, Share & Trends Analysis Report By Product (Analyzers, Reagents & Consumables), By Test...
PMcardio Queen of Hearts
PMcardio Is The First Certified Solution To Outperform Doctors in Heart Attack Detection With AI
20. November 2023 07:04 ET | Powerful Medical
PMcardio's Queen of Hearts is the first certified solution to outperform doctors in heart attack detection from the ECG using artificial intelligence.
MicrosoftTeams-image (5).png
Inotropic Agents Market Value to Surpass US$ 5.1 Bn by 2031: TMR Study
07. März 2023 14:30 ET | Transparency Market Research
Wilmington, Delaware, United States, March 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – As per a TMR study, the Inotropic Agents Market was valued at US$ 1.9 Bn in 2022 and is...
Avalon-H90 Heart Scanner
Mesuron Inc. Announces Know-How License Agreement and Stock Purchase Agreement With Mayo Clinic
04. Januar 2022 08:00 ET | Mesuron Inc.
LATHAM, N.Y., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Mesuron announced today that it has entered into a know-how collaboration agreement and stock purchase agreement with Mayo Clinic to further refine...
Cardiologists at Modern Heart and Vascular Institute
Dr. Percy Morales, Board-Certified Cardiologist & Electrophysiologist, Joins Modern Heart & Vascular
02. November 2021 10:00 ET | Modern Heart and Vascular Institute
HOUSTON, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Modern Heart and Vascular Institute is excited to welcome board-certified cardiologist and electrophysiologist Percy Francisco Morales, MD, to the team....
ZENO.png
Zenosense, Inc.: MIDS Medical JV to Receive Funding of Up to $1.2 Million
05. September 2018 07:30 ET | Zenosense, Inc.
VALENCIA, SPAIN, Sept. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and...